Self Managed Care for Heart Disease
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Self Managed Care for Heart Disease?
Is Self Managed Care for Heart Disease safe for humans?
How does the self-managed care treatment for heart disease differ from other treatments?
The self-managed care treatment for heart disease is unique because it empowers patients to actively participate in their own care, focusing on self-management strategies rather than relying solely on healthcare providers. This approach is designed to improve well-being and manage symptoms by fostering patient engagement and utilizing new modes of delivery for greater access to information.4891011
What is the purpose of this trial?
Our study aims to compare postoperative outcomes, postoperative pain and postoperative quality of lives in patients who receive the standard sternal precautions to those in patients who received self-managed sternal precautions following sternotomy for cardiac surgeries. The purpose of the study is to see if self-managed sternal precautions following sternotomy for cardiac surgeries lead to better quality of lives while maintaining same postoperative pain and rate of postoperative adverse events than standard sternal precautions. Postoperative pain and postoperative quality of lives will be assessed by phone call surveys. Postoperative outcomes will be measured by following the patients for up to a year using electronic medical record.
Research Team
Valluvan Jeevanandam, MD
Principal Investigator
Professor of Surgery
Eligibility Criteria
This trial is for English-speaking adults aged 18-70 who are undergoing a sternotomy, which is a type of heart surgery. They must be able to walk on their own. People with previous sternotomies, those getting VAD implants or cardiac transplants, or discharged over 1.5 weeks after surgery can't join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized into two groups to receive either self-managed or standard sternal precautions post-surgery
Follow-up
Participants are monitored for postoperative outcomes, pain, and quality of life for up to a year
Treatment Details
Interventions
- Self Managed Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Chicago
Lead Sponsor